Detailed Information on Publication Record
2010
ATRIAL NATRIURETIC PEPTIDE: IS ANP ASSOCIATED WITH RESTENOSIS AFTER CORONARY ARTERY STENTING?
BIENERTOVÁ VAŠKŮ, Julie, Sushruth Ganesha SWAMY, Petr BIENERT and Ota HLINOMAZBasic information
Original name
ATRIAL NATRIURETIC PEPTIDE: IS ANP ASSOCIATED WITH RESTENOSIS AFTER CORONARY ARTERY STENTING?
Name in Czech
Souvisí atriální natriuretický faktor (ANP) s rozvojem restenózy po PCI?
Authors
BIENERTOVÁ VAŠKŮ, Julie (203 Czech Republic, guarantor), Sushruth Ganesha SWAMY (826 United Kingdom of Great Britain and Northern Ireland), Petr BIENERT (203 Czech Republic) and Ota HLINOMAZ (203 Czech Republic)
Edition
I. New York, Horizons in World Cardiovascular Research, p. xxx, 8 pp. Horizons in World Cardiovascular Research, Volume2, 2010
Publisher
Nova Science Publishers, Inc.
Other information
Language
English
Type of outcome
Kapitola resp. kapitoly v odborné knize
Field of Study
Genetics and molecular biology
Country of publisher
United States of America
Confidentiality degree
obsah podléhá obchodnímu tajemství
RIV identification code
RIV/00216224:14110/10:00043948
Organization unit
Faculty of Medicine
ISBN
978-1-61668-610-9
Keywords (in Czech)
atriální natriuretický faktor; polymorfismus; SNP; restenóza; PTCA
Keywords in English
Atrial natriuretic factor; polymorphism; SNP; restenosis; PTCA
Tags
International impact, Reviewed
Změněno: 19/5/2010 16:29, prof. MUDr. Julie Dobrovolná, Ph.D.
V originále
*Atrial natriuretic factor (ANP) has shown over recent decades to play an emerging role in the regulation of coronary blood flow as well as systemic blood pressure. The common polymorphism in the atrial natriuretic peptide precursor gene (NPPA), +2238 T/C, was in the previous studies associated with hypertension as well as other cardiovascular conditions. The purpose of the study was to identify the possible relationship between the +2238 T/C polymorphism and restenosis in coronary arteries stented due to the coronary artery disease (CAD).
In Czech
*Atriální natriuretický faktor (ANP) je důležitým regulátorem průtoku krve koronárním řečištěm. Polymorfismusm +2238 T/C v genu pro prekurzor atriálního natriuretického faktoru byl již dříve asociován s koronární nemocí. V této studii jsme zkoumali efekt polymorfismu +2238 T/C na riziko vzniku restenózy po PCI s implantací stentu.